Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Diabetes Obes Metab ; 10 Suppl 4: 136-46, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18834441

RESUMEN

One of the major challenges for developmental biologists and investigators in the field of diabetes over the last few decades has been to dissect the origin of pancreatic endocrine cells and to accurately understand the mechanisms that regulate islet cell regeneration. While significant advances have been made recently, there continues to be a paucity of knowledge regarding the growth factor signalling pathways that directly regulate the proteins involved in islet cell cycle control. We will discuss recent work in these areas and provide insights from our studies into age-dependent alterations in the expression of growth factor signalling proteins and cell cycle proteins in islet cells.


Asunto(s)
Proteínas de Ciclo Celular/fisiología , Diabetes Mellitus Tipo 2/fisiopatología , Islotes Pancreáticos/fisiología , Páncreas Exocrino/fisiopatología , Envejecimiento/fisiología , Animales , Proliferación Celular , Diabetes Mellitus Tipo 2/metabolismo , Expresión Génica , Humanos , Islotes Pancreáticos/metabolismo , Páncreas Exocrino/metabolismo , Transducción de Señal/fisiología
2.
J Immunol ; 161(1): 112-21, 1998 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-9647214

RESUMEN

Proteasomes have been implicated in the production of the majority of peptides that associate with MHC class I molecules. We used two different proteasome inhibitors, the peptide aldehyde N-acetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL) and the highly specific inhibitor lactacystin, to examine the role of proteasomes in generating peptide epitopes associated with HLA-A*0201. Neither LLnL nor lactacystin was able to completely block the expression of the HLA-A*0201. Furthermore, the effects of LLnL and lactacystin on the expression of different categories of specific epitopes, TAP independent vs TAP dependent and derived from either cytosolic or membrane proteins, were assessed. As predicted, presentation of two TAP-dependent epitopes was blocked by LLnL and lactacystin, while a TAP-independent epitope that is processed in the endoplasmic reticulum was unaffected by either inhibitor. Surprisingly, both LLnL and lactacystin increased rather than inhibited the expression of a cytosolically transcribed and TAP-dependent peptide from the influenza A virus M1 protein. Mass spectrometric analyses of in vitro proteasome digests of a synthetic 24 mer containing this epitope revealed no digestion products of any length that included the intact epitope. Instead, the major species resulted from cleavage sites within the epitope. Although cleavage at these sites was inhibitable by LLnL and lactacystin, epitope-containing species were still not produced. We conclude that proteasomes may in some cases actually destroy epitopes that would otherwise be destined for presentation by class I molecules. These results suggest that some epitopes are generated by nonproteasomal proteases in the cytosol.


Asunto(s)
Cisteína Endopeptidasas/metabolismo , Cisteína Endopeptidasas/fisiología , Citosol/enzimología , Citosol/inmunología , Citotoxicidad Inmunológica , Epítopos de Linfocito T/metabolismo , Antígenos de Histocompatibilidad Clase I/metabolismo , Complejos Multienzimáticos/metabolismo , Complejos Multienzimáticos/fisiología , Transportador de Casetes de Unión a ATP, Subfamilia B, Miembro 2 , Transportadoras de Casetes de Unión a ATP/fisiología , Acetilcisteína/análogos & derivados , Acetilcisteína/farmacología , Secuencia de Aminoácidos , Animales , Línea Celular , Sistema Libre de Células/inmunología , Cisteína Endopeptidasas/efectos de los fármacos , Inhibidores de Cisteína Proteinasa/farmacología , Citotoxicidad Inmunológica/efectos de los fármacos , Epítopos de Linfocito T/biosíntesis , Epítopos de Linfocito T/efectos de los fármacos , Glicina/farmacología , Antígenos HLA-A/biosíntesis , Antígenos HLA-A/efectos de los fármacos , Humanos , Leupeptinas/farmacología , Proteínas de la Membrana/metabolismo , Ratones , Datos de Secuencia Molecular , Complejos Multienzimáticos/efectos de los fármacos , Complejo de la Endopetidasa Proteasomal , Linfocitos T Citotóxicos/enzimología , Linfocitos T Citotóxicos/inmunología , Factores de Tiempo , Proteínas de la Matriz Viral/biosíntesis , Proteínas de la Matriz Viral/inmunología
3.
Immunobiology ; 163(5): 427-35, 1982 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-6219061

RESUMEN

Mycelia from several strains of Streptomyces were potent B-lymphocyte mitogens for spleen cells from 3 inbred mouse strains (BALB/c, C3H/HeJ, C3H/nu/nu), inducing lymphocyte proliferation and differentiation into immunoglobulin-secreting cells. Streptomyces mycelia were also mitogenic towards human peripheral blood lymphocytes, where maximal stimulation was found on days 5 to 7. On the other hand, human lymphocytes incubated with the mycelia for 3 days, but not the supernatants of these cultures, strongly inhibited mixed leukocyte reactions. Irradiation experiments suggest the induction of both radioresistant and radiolabile suppressor-cell populations by the components.


Asunto(s)
Tolerancia Inmunológica , Activación de Linfocitos , Mitógenos/farmacología , Streptomyces/inmunología , Animales , Proteínas Bacterianas/inmunología , Humanos , Lipopolisacáridos/farmacología , Prueba de Cultivo Mixto de Linfocitos , Linfocitos/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Desnudos , Streptomyces/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA